National Quality Forum Endorses Ingenix-Developed Disease Management Performance Measures | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

National Quality Forum Endorses Ingenix-Developed Disease Management Performance Measures

September 15, 2010
by root
| Reprints

The National Quality Forum (NQF) has endorsed eight separate Ingenix (Eden Prarie, Minn.)-developed performance measures used by healthcare stakeholders that relate to disease management and coordination of care.

Measures endorsed by NQF are widely viewed as the most rigorous standards by which to measure health care quality, identify areas where patients are not receiving quality care, target opportunities where intervention is needed, improve outcomes and reduce health care costs.

The NQF-endorsed measures developed by Ingenix, a health care information, technology, and consulting company, address care related to diabetes (two measures), hypertension, migraine headaches, acute cerebral ischemic event, and pregnancy management (three measures). NQF endorsed the measures after a comprehensive review to determine their adherence to rigorous scientific and technical standards, as well as their ability to identify sufficient gaps in care and address national measurement priority areas. Ingenix developed measures that address potential gaps in treatment and care protocols in these areas.


Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).